Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Plataforma ISCIII de soporte para la Investigación Clínica

IP: Inmaculada Fuentes Camps
Collaborators: Gemma Vona Giralt, Antonio Moreno Galdó, Rafael Simó Canonge, Núria Pérez Picazo, Plataforma ISCIII de soporte para la Investigación Clínica , Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Joan Genescà Ferrer, Paula Isabel Roldan Caballero
Funding agency: Instituto de Salud Carlos III
Funding: 315150
Reference: PT20/00078
Duration: 01/01/2021 - 31/12/2024

T2CogVR - Structural and functional brain changes as a proxy for Virtual Reality cognitive training efficacy in Type 2 Diabetes Mellitus elderly patients

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundació "La Caixa"
Funding: 92327.22
Reference: SR20-00730
Duration: 01/02/2021 - 30/09/2024

Bloqueo intraocular de la hemopexina: una nueva estrategia para tratar el edema macular diabético

IP: Rafael Simó Canonge
Collaborators: Hugo Ramos Abellan, Patricia Bogdanov Baruj
Funding agency: Instituto de Salud Carlos III
Funding: 78100
Reference: DTS19/00171
Duration: 01/01/2020 - 31/12/2021

Incidència de complicacions de l'accés venós perifèric en la població diabètica tipus 2. Anàlisi dels factors de risc i estudi comparatiu de dos dispositius perifèrics.

IP: Rafael Simó Canonge
Collaborators: Marc Rivas Agudo, Miriam Izquierdo Sans
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 73343.84
Reference: SLT008/18/00104
Duration: 01/07/2019 - 20/03/2021

Related news

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

The study will validate the safety of a novel topical ocular administration route for sitagliptin.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Angela Vidal Jordana

Angela Vidal Jordana

Main researcher
Clinical Neuroimmunology
Read more
Elisabeth Papiol Gallofré

Elisabeth Papiol Gallofré

Shock, Organ Dysfunction and Resuscitation
Read more
Marc-Enric Fernandez Exposito

Marc-Enric Fernandez Exposito

Unitat legal
Legal Directorate
Read more
Lluis Gabalda Martinez

Lluis Gabalda Martinez

Research technician
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.